Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
4.955
+0.135 (2.80%)
Nov 21, 2024, 2:44 PM EST - Market open
MRVI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 276.92 | 288.95 | 883 | 799.24 | 284.1 | 143.14 | Upgrade
|
| Revenue Growth (YoY) | -33.99% | -67.28% | 10.48% | 181.33% | 98.48% | 15.59% | Upgrade
|
| Cost of Revenue | 148.54 | 148.74 | 168.96 | 140.56 | 79.65 | 66.85 | Upgrade
|
| Gross Profit | 128.38 | 140.2 | 714.04 | 658.68 | 204.45 | 76.29 | Upgrade
|
| Selling, General & Admin | 154.91 | 147.29 | 125.76 | 100.06 | 94.25 | 48.35 | Upgrade
|
| Research & Development | 19.25 | 17.28 | 18.37 | 15.22 | 6.42 | 3.63 | Upgrade
|
| Operating Expenses | 174.16 | 164.57 | 144.13 | 115.28 | 100.67 | 51.98 | Upgrade
|
| Operating Income | -45.78 | -24.37 | 569.92 | 543.4 | 103.78 | 24.31 | Upgrade
|
| Interest Expense | -51.84 | -45.89 | -20.41 | -30.26 | -30.74 | -29.96 | Upgrade
|
| Interest & Investment Income | 28.83 | 27.73 | 2.34 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 668.85 | 667.55 | -4.46 | 6.38 | 0.13 | 0.12 | Upgrade
|
| EBT Excluding Unusual Items | 600.06 | 625.02 | 547.38 | 519.52 | 73.17 | -5.53 | Upgrade
|
| Merger & Restructuring Charges | -9.35 | -10.57 | -3.5 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 11.25 | 19 | - | Upgrade
|
| Other Unusual Items | 4.73 | 3.29 | 7.59 | - | -7.59 | -0.32 | Upgrade
|
| Pretax Income | 441.21 | 617.74 | 551.47 | 530.77 | 81.7 | -5.85 | Upgrade
|
| Income Tax Expense | 764.32 | 756.11 | 60.81 | 61.52 | 2.88 | -0.65 | Upgrade
|
| Earnings From Continuing Operations | -323.11 | -138.38 | 490.66 | 469.25 | 78.82 | -5.2 | Upgrade
|
| Minority Interest in Earnings | 98.45 | 19.35 | -270.46 | -287.21 | 10.16 | 0.73 | Upgrade
|
| Net Income | -224.66 | -119.03 | 220.21 | 182.04 | 88.97 | -4.47 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 12.08 | 4.02 | Upgrade
|
| Net Income to Common | -224.66 | -119.03 | 220.21 | 182.04 | 76.89 | -8.49 | Upgrade
|
| Net Income Growth | - | - | 20.97% | 104.60% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 135 | 132 | 132 | 115 | 10 | 254 | Upgrade
|
| Shares Outstanding (Diluted) | 135 | 132 | 255 | 258 | 29 | 254 | Upgrade
|
| Shares Change (YoY) | -16.74% | -48.33% | -0.96% | 791.81% | -88.62% | 0.00% | Upgrade
|
| EPS (Basic) | -1.66 | -0.90 | 1.67 | 1.59 | 7.43 | -0.03 | Upgrade
|
| EPS (Diluted) | -1.66 | -0.90 | 1.67 | 1.56 | 2.36 | -0.03 | Upgrade
|
| EPS Growth | - | - | 6.97% | -33.74% | - | - | Upgrade
|
| Free Cash Flow | -10.72 | 60.67 | 518.89 | 353.72 | 126.78 | 6.97 | Upgrade
|
| Free Cash Flow Per Share | -0.08 | 0.46 | 2.03 | 1.37 | 4.39 | 0.03 | Upgrade
|
| Gross Margin | 46.36% | 48.52% | 80.87% | 82.41% | 71.96% | 53.30% | Upgrade
|
| Operating Margin | -16.53% | -8.43% | 64.54% | 67.99% | 36.53% | 16.98% | Upgrade
|
| Profit Margin | -81.13% | -41.19% | 24.94% | 22.78% | 27.06% | -5.93% | Upgrade
|
| Free Cash Flow Margin | -3.87% | 21.00% | 58.76% | 44.26% | 44.63% | 4.87% | Upgrade
|
| EBITDA | 1.04 | 15.89 | 601.75 | 568.15 | 129.62 | 48.39 | Upgrade
|
| EBITDA Margin | 0.37% | 5.50% | 68.15% | 71.09% | 45.62% | 33.81% | Upgrade
|
| D&A For EBITDA | 46.82 | 40.25 | 31.84 | 24.75 | 25.84 | 24.08 | Upgrade
|
| EBIT | -45.78 | -24.37 | 569.92 | 543.4 | 103.78 | 24.31 | Upgrade
|
| EBIT Margin | -16.53% | -8.43% | 64.54% | 67.99% | 36.53% | 16.98% | Upgrade
|
| Effective Tax Rate | 173.23% | 122.40% | 11.03% | 11.59% | 3.53% | - | Upgrade
|
| Advertising Expenses | - | 2.9 | 2.5 | 1.3 | 1.2 | 1.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.